Full Activation of the T Cell Receptor Requires Both Clustering and Conformational Changes at CD3

Immunity

Volumn 26, Issue 1, 2007, Pages 43-54

  Minguet, Susana ^a   Swamy, Mahima ^a   Alarcón, Balbino ^b   Luescher, Immanuel F ^c   Schamel, Wolfgang W A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

MOLIMMUNO; SIGNALING

Indexed keywords

CD3 ANTIGEN; CD69 ANTIGEN; RECEPTOR SUBUNIT; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL ACTIVATION; CELL ASSAY; CELL MEMBRANE; CLUSTER ANALYSIS; COMPLEX FORMATION; CYTOPLASM; DISSOCIATION; GEOMETRY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTRACELLULAR TRANSPORT; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; ANTIGENS, CD3; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSFECTION;

EID: 33846224785     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.10.019     Document Type: Article

References (51)

1. Abastado J.P., Lone Y.C., Casrouge A., Boulot G., and Kourilsky P. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J. Exp. Med. 182 (1995) 439-447
2. Aivazian D., and Stern L.J. Phosphorylation of T cell receptor ζ is regulated by a lipid dependent folding transition. Nat. Struct. Biol. 7 (2000) 1023-1026
3. Alarcon B., Gil D., Delgado P., and Schamel W.W.A. Initiation of TCR signaling: regulation within CD3 dimers. Immunol. Rev. 191 (2003) 38-46
4. Arcaro A., Gregoire C., Bakker T.R., Baldi L., Jordan M., Goffin L., Boucheron N., Wurm F., van der Merwe P.A., Malissen B., and Luescher I.F. CD8β endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. J. Exp. Med. 194 (2001) 1485-1495
5. Arnett K.L., Harrison S.C., and Wiley D.C. Crystal structure of a human CD3ε/δ dimer in complex with a UCHT1 single-chain antibody fragment. Proc. Natl. Acad. Sci. USA 101 (2004) 16268-16273
6. Bankovich A.J., and Garcia K.C. Not just any T cell receptor will do. Immunity 18 (2003) 7-11
7. Boniface J.J., Rabinowitz J.D., Wülfing C., Hampl J., Reich Z., Altman J.D., Kantor R.M., Beeson C., McConnell H.M., and Davis M.M. Initiation of signal transduction through the T cell receptor requires the peptide multivalent engagement of MHC ligands. Immunity 9 (1998) 459-466
8. Buslepp J., Wang H., Biddison W.E., Appella E., and Collins E.J. A correlation between TCR Vα docking on MHC and CD8 dependence: implications for T cell selection. Immunity 19 (2003) 595-606
9. Call M.E., Pyrdol J., Wiedmann M., and Wucherpfennig K.W. The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111 (2002) 967-979
10. Cebecauer M., Guillaume P., Mark S., Michielin O., Boucheron N., Bezard M., Meyer B.H., Segura J.M., Vogel H., and Luescher I.F. CD8+ cytotoxic T lymphocyte activation by soluble major histocompatibility complex-peptide dimers. J. Biol. Chem. 280 (2005) 23820-23828
11. Choudhuri K., Kearney A., Bakker T.R., and van der Merwe P.A. Immunology: how do T cells recognize antigen?. Curr. Biol. 15 (2005) R382-R385
12. Cochran J.R., Cameron T.O., and Stern L.J. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity 12 (2000) 241-250
13. Cochran J.R., Aivazian D., Cameron T.O., and Stern L.J. Receptor clustering and transmembrane signaling in T cells. Trends Biochem. Sci. 26 (2001) 304-310
14. Coombs D., Kalergis A.M., Nathenson S.G., Wofsy C., and Goldstein B. Activated TCRs remain marked for internalization after dissociation from pMHC. Nat. Immunol. 3 (2002) 926-931
15. Ding Y.H., Baker B.M., Garboczi D.N., Biddison W.E., and Wiley D.C. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 11 (1999) 45-56
16. Doucey M.A., Goffin L., Naeher D., Michielin O., Baumgartner P., Guillaume P., Palmer E., and Luescher I.F. CD3δ establishes a functional link between the T cell receptor and CD8. J. Biol. Chem. 278 (2003) 3257-3264
17. Garboczi D.N., Ghosh P., Utz U., Fan Q.R., Biddison W.E., and Wiley D.C. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384 (1996) 134-141
18. Germain R.N. The T cell receptor for antigen: signaling and ligand discrimination. J. Biol. Chem. 276 (2001) 35223-35226
19. Gil D., Schamel W.W., Montoya M., Sanchez-Madrid F., and Alarcon B. Recruitment of Nck by CD3ε reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation. Cell 109 (2002) 901-912
20. Gil D., Schrum A.G., Alarcon B., and Palmer E. T cell receptor engagement by peptide-MHC ligands induces a conformational change in the CD3 complex of thymocytes. J. Exp. Med. 201 (2005) 517-522
21. Gregoire C., Lin S.Y., Mazza G., Rebai N., Luescher I.F., and Malissen B. Covalent assembly of a soluble T cell receptor-peptide-major histocompatibility class I complex. Proc. Natl. Acad. Sci. USA 93 (1996) 7184-7189
22. Hewitt C.R., Lamb J.R., Hayball J., Hill M., Owen M.J., and O'Hehir R.E. Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J. Exp. Med. 175 (1992) 1493-1499
23. Hoey T., Sun Y.L., Williamson K., and Xu X. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 2 (1995) 461-472
24. Janeway C.A.J. Ligands for the T-cell receptor: hard times for avidity models. Immunol. Today 16 (1995) 223-225
25. Kalergis A.M., Goyarts E.C., Palmieri E., Honda S., Zhang W., and Nathenson S.G. A simplified procedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I. J. Immunol. Methods 234 (2000) 61-70
26. Kaye J., and Janeway Jr. C.A. The Fab fragment of a directly activating monoclonal antibody that precipitates a disulfide-linked heterodimer from a helper T cell clone blocks activation by either allogeneic Ia or antigen and self-Ia. J. Exp. Med. 159 (1984) 1397-1412
27. Kjer-Nielsen L., Clements C.S., Purcell A.W., Brooks A.G., Whisstock J.C., Burrows S.R., McCluskey J., and Rossjohn J. A structural basis for the selection of dominant αβ T cell receptors in antiviral immunity. Immunity 18 (2003) 53-64
28. Krishna S., Benaroch P., and Pillai S. Tetrameric cell-surface MHC class I molecules. Nature 357 (1992) 164-167
29. Krogsgaard M., Li Q.J., Sumen C., Huppa J.B., Huse M., and Davis M.M. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature 434 (2005) 238-243
30. Luescher I.F., Romero P., Cerottini J.C., and Maryanski J.L. Specific binding of antigenic peptides to cell-associated MHC class I molecules. Nature 351 (1991) 72-74
31. Luescher I.F., Vivier E., Layer A., Mahiou J., Godeau F., Malissen B., and Romero P. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373 (1995) 353-356
32. Malissen B. An evolutionary and structural perspective on T cell antigen receptor function. Immunol. Rev. 191 (2003) 7-27
33. McKeithan T.W. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA 92 (1995) 5042-5046
34. Minguet S., Huber M., Rosenkranz L., Schamel W.W., Reth M., and Brummer T. Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. Eur. J. Immunol. 35 (2005) 31-41
35. Reiser J.B., Gregoire C., Darnault C., Mosser T., Guimezanes A., Schmitt-Verhulst A.M., Fontecilla-Camps J.C., Mazza G., Malissen B., and Housset D. A T cell receptor CDR3β loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16 (2002) 345-354
36. Reth M., Imanishi-Kari T., and Rajewsky K. Analysis of the repertoire of anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in C57BL/6 mice by cell fusion. II. Characterization of idiotopes by monoclonal anti-idiotope antibodies. Eur. J. Immunol. 12 (1979) 1004-1013
37. Risueno R.M., Gil D., Fernandez E., Sanchez-Madrid F., and Alarcon B. Ligand-induced conformational change in the T-cell receptor associated with productive immune synapses. Blood 106 (2005) 601-608
38. Rojo J.M., and Janeway Jr. C.A. The biological activity of anti-T cell receptor variable region monoclonal antibodies is determined by the epitope recognized. J. Immunol. 140 (1988) 1081-1088
39. Rudolph M.G., Stanfield R.L., and Wilson I.A. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24 (2006) 419-466
40. San Jose E., Sahuquillo A.G., Bragado R., and Alarcon B. Assembly of the TCR/CD3 complex: CD3ε/δ and CD3ε/γ dimers associate indistinctly with both TCRα and TCRβ chains. Evidence for a double TCR heterodimer model. Eur. J. Immunol. 28 (1998) 12-21
41. Schafer P.H., Pierce S.K., and Jardetzky T.S. The structure of MHC class II: a role for dimer of dimers. Semin. Immunol. 7 (1995) 389-398
42. Schamel W.W., Kuppig S., Becker B., Gimborn K., Hauri H.P., and Reth M. A high molecular weight complex of BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 100 (2003) 9861-9866
43. Schamel W.W., Arechaga I., Risueno R.M., van Santen H.M., Cabezas P., Risco C., Valpuesta J.M., and Alarcon B. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response. J. Exp. Med. 202 (2005) 493-503
44. Schamel W.W., Risueno R.M., Minguet S., Ortiz A.R., and Alarcon B. A conformation- and avidity-based proofreading mechanism for the TCR-CD3 complex. Trends Immunol. 27 (2006) 176-182
45. Sigalov A. Multi-chain immune recognition receptors: spatial organization and signal transduction. Semin. Immunol. 17 (2005) 51-64
46. Stone J.D., and Stern L.J. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement. J. Immunol. 176 (2006) 1498-1505
47. Sun Z.Y.S., Seok Kim K., Wagner G., and Reinherz E.L. Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3εγ heterodimer. Cell 105 (2001) 913-923
48. Szymczak A.L., Workman C.J., Gil D., Dilioglou S., Vignali K.M., Palmer E., and Vignali D.A. The CD3ε proline-rich sequence, and its interaction with Nck, is not required for T cell development and function. J. Immunol. 175 (2005) 270-275
49. Valitutti S., Muller S., Cella M., Padovan E., and Lanzavecchia A. Serial Triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375 (1995) 148-151
50. Wedemayer G.J., Patten P.A., Wang L.H., Schultz P.G., and Stevens R.C. Structural insights into the evolution of an antibody combining site. Science 276 (1997) 1665-1669
51. Wu L.C., Tuot D.S., Lyons D.S., Garcia K.C., and Davis M.M. Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature 418 (2002) 552-556